Press

Press
22. October 2020

Innovation leader for large-scale battery storage monitoring NOVUM secures capital increase for product portfolio expansion

Dr. Hettich Beteiligungen and High-Tech Gründerfonds (HTGF) invest a 7-digit sum in the battery monitoring start-up NOVUM. NOVUM has developed a patented technology which now makes large-scale battery storage monitoring possible offline. The new capital shall be used to expand the product portfolio in the field of large-scale storage and 2nd life quick tests for the automotive industry. The determination of battery charge and wear status still remains a challenge in many cases. Most larg
 
Press
21. October 2020

Successful exit for High-Tech Gründerfonds and Evonik Venture Capital – Synoste Oy becomes part of Globus Medical

Globus Medical, based in Audubon, Pennsylvania, USA, is a leading medical device manufacturerThe Finnish start-up Synoste, with offices in Helsinki and Düsseldorf, develops high-tech implants for minimally invasive treatment of leg length discrepancyThe transaction marks HTGF’s 11th successful exit during the coronavirus crisis High-Tech Gründerfonds (HTGF) and Evonik Venture Capital have exited Finnish start-up Synoste Oy. US based Globus Medical (NYSE: GMED) acquired all shares. Hig
 
HTGF Exit ChromoTek
Press
20. October 2020

Successful exit for High-Tech Gründerfonds and Bayern Kapital –
Proteintech acquires ChromoTek

Proteintech, which is based in Chicago, Illinois, USA, is the benchmark in antibodiesMartinsried-based startup ChromoTek is a market leader in nanobodiesThe acquisition enables Proteintech to expand its next-generation antibody toolsBayern Kapital and HTGF arranged the seed financing in 2010The transaction marks HTGF’s 10th successful exit during the coronavirus crisis High-Tech Gründerfonds and Bayern Kapital have sold their shares in ChromoTek after having spent 10 years at the start
 
Press
20. October 2020

HTGF portfolio company: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19Atriva’s ATR-002 molecule is the only host-cell targeting antiviral therapeutic specifically developed to treat severe respiratory infections caused by RNA (ribonucleic acid) viruses – it may prevent progression to critical-stage COVID-19 in hospitalised patients and holds stro
 
Logo Digital Health Startup Heartbeat Medical Solutions - HTGF Start-up VC Finanzierung
Press
5. October 2020

btov Partners, HV Holtzbrinck Ventures and HTGF invest in Real World Evidence and Patient-Reported Outcomes: 5 million euros for heartbeat medical

New standards for care management are set by connecting and utilising clinical data alongside data tracking patient-provided perspectives on their health status over timeFundamental trend in health care: Patient-Reported Outcome Measures (PROMS) and Real World Evidence (RWE)Over 200 hospital teams, registries and research institutions have registered to use the platform registered as a CE-marked medical device The digital health start-up heartbeat medical has closed a Series A financing r
 
Press
1. October 2020

Neuromodulation pioneer WISE closes EUR 15M Series C financing round
to launch second product, SCS EXPERT, for chronic pain

SCS EXPERT – first expandable percutaneous lead for neuromodulation treatment of chronic painNew investors, CDP Venture Capital and Eureka!, join existing participating investors in financing roundAdds to EUR 2.3M grant earlier in 2020 from the European Commission to launch SCS EXPERT WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the closing of a EUR 15 million Serie
 
Press
1. October 2020

Grandperspective GmbH secures seed financing

Making gas leaks in the chemical industry visible from kilometres away Over 30% of major leaks of toxic of flammable industrial gases remain undetected by gas sensors. Grandperspective develops with the scanfeldTM world’s first early warning solution monitoring entire chemical parks for gas leaks. The High-Tech Gründerfond (HTGF) finances this innovation in cooperation with Brandburg Kapital, DiaMedCare and various business angels. The scanfeldTM early warning solution combines
 
Press
29. September 2020

Successful Exit for High-Tech Gründerfonds – Zoovu and SEMKNOX Merger

Zoovu, is the global leader in Conversational SearchThe Startup SEMKNOX, based in Dresden, perfectly complements the core business of ZoovuSeed investors WestTech Ventures and High-Tech Gründerfonds (HTGF) as well as business angels Tobias Kroha and Dr. David Monbaron sell their sharesFor the HTGF it is the 9th successful exit during the Corona crisis The High-Tech Gründerfonds sold its shares in SEMKNOX after accompanying the company for the past 5 years. Zoovu Boston, USA, is provider
 
Press
16. September 2020

Betterfront completes seed financing from HTGF to bring private equity fund raising to the next level

Private equity fund managers can say goodbye to the madness of the capital-raising process thanks to Betterfront’s data-driven fundraising platform. The company provides fund managers with a fundraising and data analytics platform, which generates insights that drive allocators’ investment decisions. High-Tech Gründerfonds led the seed round and was joined by a group of angel investors. Betterfront closed an oversubscribed seed round. HTGF led the financing with the participation of
 
Press
15. September 2020

Successful Exit for High-Tech Gründerfonds – Intersect ENT acquires Fiagon

Buyer is the Intersect ENT, a medical technology company based in the USThe startup Fiagon AG Medical Technologies expands Intersects portfolio of ENT product offeringsFor the HTGF it is the 8th successful exit during the Corona crisis The High-Tech Gründerfonds sold its shares in Fiagon. The seed investor has accompanied the company for 11 years. The publicly traded company Intersect ENT (NASDAQ: XENT), Menlo Park, California, USA, is dedicated to transforming  the treatment of ear
 
Press
10. September 2020

Educate machines to read: Deep-Tech Startup Natif.ai secures seed financing

The Saarbrücken-based Deep-Tech Startup Natif.ai announces the successful closing of a seven-digit financing round with the lead investor High-Tech Gründerfonds (HTGF). Thanks to revolutionary AI models and a self-developed Deep-OCR, various documents can be analyzed extremely quickly, accurately and relevant data can be extracted. Natif.ai thus enables a fast and efficient way to productively bring artificial intelligence into the economy. With this financing, the founding team is investi
 
Press
8. September 2020

bookingkit receives Millions in additional Strategic Investment Capital

bookingkit, Europe’s leading Software-as-a-Service company for providers of tours, attractions and activities, emerges strengthened from the Covid-19 crisis: The industry-wide dip in tourism-related revenue after the Europe-wide contact restrictions in spring is now facing a strongly accelerated sales development. In order to make strategic use of this momentum and further expand its position in various European markets, the Berlin-based company is receiving additional capital in the m
 
Press
8. September 2020

Successful Exit for High-Tech Gründerfonds – fos4X becomes part of PolyTech

Buyer is the Danish wind technology company PolyTechThe Munich startup fos4X perfectly complements the core business of the buyerSeed investors Bayern Kapital, HTGF and UVC Partners sell their sharesFor the HTGF it is the 7th successful exit during the Corona crisis The High-Tech Gründerfonds sold its shares in fos4X today. The seed investor has accompanied the company for 8 years. The buyer, PolyTech is the leading development, test, production and service company for the wind power ind
 
Press
3. September 2020

Computer-Brain-Interface Company CereGate Closed Series A Financing Round

The Healthtech VC Heal Capital led the round with participation of HTGF and TruVenturo CereGate, a leading German neurostimulation company developing a software-based Computer-Brain-Interface (CBI), today announced the successful closing of a series A financing round led by the new European healthtech VC Heal Capital with participation from the existing investors High-Tech Gründerfonds (HTGF) and TruVenturo. The parties agreed to not disclose any further details of the financing round.
 
15 Jahre HTGF
Press
1. September 2020

Europe’s most active seed investor: High-Tech Gründerfonds celebrates 15-year anniversary

High-Tech Gründerfonds is celebrating its 15-year anniversary. To mark the occasion, the company is starting a number of initiatives. On 15 September, a new podcast will be launched hosted by Managing Director Dr. Alex von Frankenberg and featuring 15 guests on the subjects of digitalisation and innovation. In addition, a series of online seminars for founders will be started, in which HTGF will share the knowledge it has accumulated over 15 years, during which time it has provided seed fun
 
Press
28. August 2020

Aignostics raises €5m Seed Round to advance AI-powered pathology

Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, with participation from the High-Tech Gründerfonds (HTGF), VC Fonds Technologie der IBB Beteiligungsgesellschaft, and Future Capital. Aignostics formally started out in early 2018, when r